key: cord-1010553-7a8ouzma
authors: Ruocco, Gaetano; Feola, Mauro; Palazzuoli, Alberto
title: Hypertension prevalence in human Coronavirus: The role of ACE system in infection spread and severity
date: 2020-04-24
journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
DOI: 10.1016/j.ijid.2020.04.058
sha: 24cb65fc58286117efabba5f9b2ff6f849081bbe
doc_id: 1010553
cord_uid: 7a8ouzma

Summary The prevalence of hypertension is high in patients affected by COVID infection and it appears related to increased risk of mortality in many epidemiological studies. The ACE system is not uniformly expressed in all the human races, and current differences could hypothesize some geographical discrepancies of infection around the world. However, animal studies showed that ACE2 receptor is a potential pathway for host infection. Because two third of the hypertensive patients take ACE-i/ARB, several concerns have been raised about the detrimental role of current drugs. In this report we summarized the current evidences in favour or against the administration of ACE blockade in the COVID era.

The prevalence of hypertension is high in patients affected by COVID infection and it appears 32 related to increased risk of mortality in many epidemiological studies. The ACE system is not 33 uniformly expressed in all the human races, and current differences could hypothesize some 34 geographical discrepancies of infection around the world. However, animal studies showed that 35 ACE2 receptor is a potential pathway for host infection. Because two third of the hypertensive 36 patients take ACE-i/ARB, several concerns have been raised about the detrimental role of current 37 drugs. In this report we summarized the current evidences in favour or against the administration of 38 ACE blockade in the COVID era.

The blockage of angiotensin converting enzyme (ACE) system is the milestone of treatment in 41 several conditions ranging from hypertension until heart failure. Inhibition of ACE has also 42 demonstrated favourable effect in many metabolic diseases such as diabetes, obesity and chronic 43 kidney disease progression. In clinical practice exist two main drugs able to modulate ACE system: However by now any large cohort studies evidenced a relationship, and these assumption has been 50 purposed on the basis of some bio molecular evidences.

[1] The first large scale analysis of Chinese 51 population affected by Covid-19 demonstrated that 15% was affected by hypertension. However a 52 small percentage of these patients were treated and only a quarter were treated with ACE-I/ARBs.

[2] Indeed, in general Chinese population hypertension prevalence ranging about from 18% to 25% 54 and only an half of them were treated. Looking for occidental countries, the rate of hypertension 55 was higher with respect to Chinese people, ranging from 20% to 35% in relation to age, ethnicity, China. Despite these epidemiological findings, a recent paper showed in a population based cohort, 65 that black American have an higher incidental rate of adverse events. This is probably due to poor 66 social economic condition, dietary lifestyle and scarce respect of distance rule and facial musk 67 wearing. [5] 68

The mechanisms related to the potential liaison between hypertension and ACE system modulation, 

COVID-19 and African Americans